The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Kennedy testified before the House Energy and Commerce Health Subcommittee about health spending cuts and health agency ...

MIT and Scripps scientists explore a single-dose vaccine approach by combining two immune-boosting ingredients.

Kennedy said that Pallone had previously been a champion of people who had been harmed by vaccines and only changed his tune ...

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

Immuno Cure BioTech and PharmaJet are working together on a clinical study to test the effectiveness of PharmaJet’s ...

In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...